18h
GlobalData on MSNFDA approves AstraZeneca’s Imfinzi combo for bladder cancerThe US Food and Drug Administration (FDA) has approved AstraZeneca's human monoclonal antibody Imfinzi (durvalumab) with ...
Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...
Approval was based on improved survival outcomes vs platinum-based chemotherapy as demonstrated in the phase 3 NIAGARA study.
Terry Bradshaw, the NFL legend, faced double cancer diagnoses of bladder and skin cancer. This reshaped his life, making him ...
The promotional effort from Ferring features bladder cancer survivors sharing the news of a new treatment option.
AstraZeneca has secured another expansion of its Imfinzi for use in cancer patients before and after surgery. | Imfinzi is ...
13h
Zacks Investment Research on MSNAstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer IndicationAstraZeneca AZN announced that the FDA has approved its blockbuster drug, Imfinzi (durvalumab), for a bladder cancer ...
Learn the 7 vital bladder cancer warning signs that require immediate medical attention, including subtle early symptoms many ...
AstraZeneca (AZ) has announced that its Imfinzi (durvalumab) perioperative regimen has been approved by the US Food and Drug ...
Leveraging the power of AI and machine learning technologies, researchers developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.
AstraZenecas drug Imfinzi (NASDAQ: AZN) has received U.S. approval to treat adult patients with muscle-invasive bladder ...
6don MSN
Army bomb disposal veterans may have a significantly increased risk of developing bladder cancer compared to the general ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results